These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24840646)

  • 1. Inactivation of p53 is insufficient to allow B cells and B-cell lymphomas to survive without Dicer.
    Adams CM; Eischen CM
    Cancer Res; 2014 Jul; 74(14):3923-34. PubMed ID: 24840646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival.
    Arrate MP; Vincent T; Odvody J; Kar R; Jones SN; Eischen CM
    Cancer Res; 2010 Jul; 70(14):6083-92. PubMed ID: 20587524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIF loss impairs Myc-induced lymphomagenesis.
    Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
    Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
    Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
    Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.
    Nemajerova A; Petrenko O; Trümper L; Palacios G; Moll UM
    J Clin Invest; 2010 Jun; 120(6):2070-80. PubMed ID: 20484818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
    Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
    Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dicer cooperates with p53 to suppress DNA damage and skin carcinogenesis in mice.
    Lyle S; Hoover K; Colpan C; Zhu Z; Matijasevic Z; Jones SN
    PLoS One; 2014; 9(6):e100920. PubMed ID: 24979267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
    Högstrand K; Grandien A
    Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicer Is Required for Normal Cerebellar Development and to Restrain Medulloblastoma Formation.
    Zindy F; Lee Y; Kawauchi D; Ayrault O; Merzoug LB; Li Y; McKinnon PJ; Roussel MF
    PLoS One; 2015; 10(6):e0129642. PubMed ID: 26091048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
    Eischen CM; Alt JR; Wang P
    Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas.
    Gostissa M; Bianco JM; Malkin DJ; Kutok JL; Rodig SJ; Morse HC; Bassing CH; Alt FW
    Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2934-9. PubMed ID: 23382223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon 1 disruption alters tissue-specific expression of mouse p53 and results in selective development of B cell lymphomas.
    Chiang YJ; Difilippantonio MJ; Tessarollo L; Morse HC; Hodes RJ
    PLoS One; 2012; 7(11):e49305. PubMed ID: 23166633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant mice lacking alternatively spliced p53 isoforms unveil
    Fajac A; Simeonova I; Leemput J; Gabriel M; Morin A; Lejour V; Hamon A; Rakotopare J; Vaysse-Zinkhöfer W; Eldawra E; Pinskaya M; Morillon A; Bourdon JC; Bardot B; Toledo F
    Elife; 2024 Sep; 13():. PubMed ID: 39298333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.
    Odvody J; Vincent T; Arrate MP; Grieb B; Wang S; Garriga J; Lozano G; Iwakuma T; Haines DS; Eischen CM
    Oncogene; 2010 Jun; 29(22):3287-96. PubMed ID: 20305689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
    Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
    Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.
    Michalak EM; Jansen ES; Happo L; Cragg MS; Tai L; Smyth GK; Strasser A; Adams JM; Scott CL
    Cell Death Differ; 2009 May; 16(5):684-96. PubMed ID: 19148184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.
    Gramling MW; Eischen CM
    Cell Death Differ; 2012 Jul; 19(7):1220-7. PubMed ID: 22301919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.